Donadio Jamie A 4
4 · Mirati Therapeutics, Inc. · Filed Mar 2, 2018
Insider Transaction Report
Form 4
Donadio Jamie A
VP of Finance
Transactions
- Exercise/Conversion
Common Stock
2018-03-01$5.50/sh+9,375$51,563→ 9,375 total - Exercise/Conversion
Common Stock
2018-03-01$5.40/sh+12,500$67,500→ 21,875 total - Exercise/Conversion
Common Stock
2018-03-01$7.30/sh+30,000$219,000→ 51,875 total - Sale
Common Stock
2018-03-01$26.78/sh−25,600$685,514→ 26,275 total - Sale
Common Stock
2018-03-01$27.45/sh−25,775$707,591→ 500 total - Sale
Common Stock
2018-03-01$28.08/sh−500$14,040→ 0 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2018-03-01−9,375→ 20,625 totalExercise: $5.50Exp: 2026-10-26→ Common Stock (9,375 underlying) - Exercise/Conversion
Employee Stock Option (Right to Buy)
2018-03-01−12,500→ 37,500 totalExercise: $5.40Exp: 2027-01-25→ Common Stock (12,500 underlying) - Exercise/Conversion
Employee Stock Option (Right to Buy)
2018-03-01−30,000→ 0 totalExercise: $7.30Exp: 2020-03-19→ Common Stock (30,000 underlying)
Footnotes (6)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 21, 2017.
- [F2]1/4th of the shares subject to the Option shall vest and become exercisable on the first anniversary of the date of grant, and 1/48th of the shares subject to the Option shall vest each month thereafter until fully vested.
- [F3]Twenty percent (20%) of the shares subject to the stock option vested and became exercisable on the grant date of the option (March 20, 2013), and an additional 20% shall vest and become exercisable each year on the anniversary of the grant date.
- [F4]This transaction was executed in multiple trades at prices ranging from $26.05 to $27.025. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F5]This transaction was executed in multiple trades at prices ranging from $27.05 to $28.00. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F6]This transaction was executed in multiple trades at prices ranging from $28.05 to $28.20. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.